N-acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: Results from the cardiac angiography in renally impaired patients study

Journal of Interventional Cardiology

Volumn 22, Issue 3, 2009, Pages 261-265

  Staniloae, Cezar S ^a   Doucet, Serge ^b   Sharma, Samin K ^c   Katholi, Richard E ^d   Mody, Kanika R ^a   Coppola, John T ^a   Solomon, Richard ^e  

^a ST VINCENT S HOSPITAL MANHATTAN   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY   (United States)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; IODIXANOL; IOPAMIDOL; BUFFER; IODOBENZOIC ACID DERIVATIVE; PLASMA SUBSTITUTE; SCAVENGER;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG TREATMENT FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; KIDNEY DISEASE; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK FACTOR;

ACETYLCYSTEINE; AGED; BUFFERS; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; FREE RADICAL SCAVENGERS; GLOMERULAR FILTRATION RATE; HUMANS; IOPAMIDOL; KIDNEY DISEASES; MALE; PLASMA SUBSTITUTES; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM BICARBONATE; TRIIODOBENZOIC ACIDS;

EID: 66749132785     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00456.x     Document Type: Article

References (24)

1. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997 103 : 368 375. (Pubitemid 27506242)
2. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000 36 : 1542 1548.
3. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006 354 : 379 386.
4. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: A clinical and evidence-based approach. Circulation 2006 113 : 1799 1806. (Pubitemid 43958473)
5. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008 52 : 599 604.
6. Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs. sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. JAMA 2008 300 : 1038 1046.
7. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003 362 : 598 603. (Pubitemid 37013299)
8. Briguori C, Airoldi F, D'Andrea D, et al. Renal Insufficiency following contrast media administration trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007 115 : 1211 1217. (Pubitemid 46594764)
9. Hizoh I, Strater J, Schick CS, et al. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: Role of hypertonicity. Nephrol Dial Transplant 1998 13 : 911 918. (Pubitemid 28161763)
10. Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac angiography in renally impaired patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007 115 : 3189 3196. (Pubitemid 47012233)
11. Johnson CA, Levey AS, Coresh J, et al. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 2004 70 : 869 876.
12. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994 331 : 1416 1420. (Pubitemid 24348355)
13. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002 162 : 329 336. (Pubitemid 34127411)
14. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004 291 : 2328 2334. (Pubitemid 38656299)
15. Bakris GL, Lass N, Gaber AO, et al. Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 1990 258 : F115 F120.
16. Katholi RE, Woods WT, Jr., Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998 32 : 64 71. (Pubitemid 28311873)
17. Briguori C, Colombo A, Violante A, et al. Standard vs. double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004 25 : 206 211. (Pubitemid 38235156)
18. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002 89 : 356 358. (Pubitemid 34113804)
19. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 2003 289 : 553 558. (Pubitemid 37428626)
20. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002 40 : 1383 1388. (Pubitemid 35192860)
21. Allaqaband S, Tumuluri R, Malik AM, et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002 57 : 279 283. (Pubitemid 35266257)
22. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002 62 : 2202 2207. (Pubitemid 35366176)
23. Rehman T, Fought J, Solomon R. N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 2008 3 : 1610 1614.
24. Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO study. J Am Coll Cardiol 2007 49 : 1283 1288. (Pubitemid 46467227)